ArticleFrontiers in endocrinology2026
Associations of clinical obesity with arterial stiffness and cerebral small vessel disease: a population-based study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Based on the comprehensive indicator of clinical obesity, this study investigates its association with arterial stiffness and cerebral small vessel disease (cSVD). Methods: This cross-sectional study analyzed 2,011 adults from the Multimodal Imaging Study based on the Kailuan Cohort. From 2021 to 2024, participants underwent Brain magnetic resonance imaging scans and obesity assessments. We used logistic regression models to evaluate associations between clinical obesity, arterial stiffness, and cSVD, adjusting for age, sex, smoking history, drinking history, physical activity, glucose-lowering medication, lipid-lowering medication, homocysteine, C-reactive protein, and low-density lipoprotein cholesterolMediation analysis tested whether arterial stiffness mediated the obesity-cSVD relationship. Results: A total of 2,011 participants (49.8% male, mean age 53.7 ± 12.2 years) were included. Clinical obesity was significantly associated with a higher total burden of cSVD, and the strength of its association with specific imaging markers decreased in the following order: perivascular spaces (PVS), lacunar infarcts, white matter hyperintensities (WMH), and cerebral microbleeds (CMB). Arterial stiffness significantly mediated the association between clinical obesity and cSVD. Conclusions: Clinical obesity was significantly associated with cSVD, with its association varying across specific imaging markers. Arterial stiffness mediates this relationship, suggesting that targeting obesity and arterial stiffness may help prevent subclinical cerebrovascular damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.